AR222178A1 - Procedimiento para preparar compuestos de 2-aza-6-alquil(c1-c3)-8-o 9-ergoleno y sus sales - Google Patents

Procedimiento para preparar compuestos de 2-aza-6-alquil(c1-c3)-8-o 9-ergoleno y sus sales

Info

Publication number
AR222178A1
AR222178A1 AR277116A AR27711679A AR222178A1 AR 222178 A1 AR222178 A1 AR 222178A1 AR 277116 A AR277116 A AR 277116A AR 27711679 A AR27711679 A AR 27711679A AR 222178 A1 AR222178 A1 AR 222178A1
Authority
AR
Argentina
Prior art keywords
ergolene
aza
salts
alkyl
procedure
Prior art date
Application number
AR277116A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of AR222178A1 publication Critical patent/AR222178A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06Peri-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/06Ring systems of three rings
    • C07D221/10Aza-phenanthrenes

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychology (AREA)
  • Anesthesiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AR277116A 1979-03-16 1979-06-29 Procedimiento para preparar compuestos de 2-aza-6-alquil(c1-c3)-8-o 9-ergoleno y sus sales AR222178A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/021,055 US4201862A (en) 1979-03-16 1979-03-16 2-Azaergolines and 2-aza-8(or 9)-ergolenes

Publications (1)

Publication Number Publication Date
AR222178A1 true AR222178A1 (es) 1981-04-30

Family

ID=21802089

Family Applications (1)

Application Number Title Priority Date Filing Date
AR277116A AR222178A1 (es) 1979-03-16 1979-06-29 Procedimiento para preparar compuestos de 2-aza-6-alquil(c1-c3)-8-o 9-ergoleno y sus sales

Country Status (31)

Country Link
US (1) US4201862A (es)
EP (1) EP0016274B1 (es)
JP (1) JPS55124782A (es)
AR (1) AR222178A1 (es)
AT (1) AT371465B (es)
AU (1) AU528075B2 (es)
BE (1) BE877263A (es)
CA (2) CA1107275A (es)
CH (1) CH641803A5 (es)
CS (1) CS213380B2 (es)
DD (1) DD144671A5 (es)
DE (1) DE2964803D1 (es)
DK (1) DK268379A (es)
EG (1) EG14250A (es)
ES (1) ES8202341A1 (es)
FI (1) FI66381C (es)
FR (1) FR2451375A1 (es)
GB (1) GB2044247B (es)
GR (1) GR72397B (es)
HU (1) HU181678B (es)
IE (1) IE48360B1 (es)
IL (1) IL57667A (es)
LU (1) LU81437A1 (es)
NZ (1) NZ190832A (es)
PH (1) PH15302A (es)
PL (1) PL128622B1 (es)
PT (1) PT69832A (es)
RO (1) RO76166A (es)
SU (1) SU1005662A3 (es)
YU (1) YU154679A (es)
ZA (1) ZA793246B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL65269A0 (en) * 1981-03-24 1982-05-31 Lilly Co Eli 6-substituted hexahydroindazolo or hexahydroisoindolo isoquinolines
GB2112382B (en) * 1981-11-06 1985-03-06 Erba Farmitalia Ergoline derivatives
GB8419278D0 (en) * 1984-07-27 1984-08-30 Lilly Industries Ltd Pharmaceutical compounds
US4798834A (en) * 1987-08-31 1989-01-17 Eli Lilly And Company Optionally substituted (3β-9,10-didehydro-2,3-dihydro ergoline as serotonergic function enhancement
JPH02111285U (es) * 1989-02-27 1990-09-05
JPH0625197U (ja) * 1992-01-14 1994-04-05 森下株式会社 網製輸送袋

Also Published As

Publication number Publication date
RO76166A (ro) 1981-11-04
CH641803A5 (fr) 1984-03-15
CA1142176B (en) 1983-03-01
AU528075B2 (en) 1983-04-14
US4201862A (en) 1980-05-06
EG14250A (en) 1983-12-31
IL57667A (en) 1983-06-15
EP0016274A1 (en) 1980-10-01
PL216720A1 (es) 1981-01-30
ATA452379A (de) 1982-11-15
NZ190832A (en) 1983-07-15
CA1107275A (en) 1981-08-18
BE877263A (fr) 1979-12-27
GB2044247B (en) 1983-08-17
IE48360B1 (en) 1984-12-26
ZA793246B (en) 1981-02-25
FI66381C (fi) 1984-10-10
GR72397B (es) 1983-11-01
GB2044247A (en) 1980-10-15
FI792044A (fi) 1980-09-17
AT371465B (de) 1983-06-27
FR2451375B1 (es) 1982-02-19
YU154679A (en) 1983-10-31
IL57667A0 (en) 1979-10-31
FI66381B (fi) 1984-06-29
IE791212L (en) 1980-09-16
CS213380B2 (en) 1982-04-09
EP0016274B1 (en) 1983-02-16
ES482092A0 (es) 1980-08-01
SU1005662A3 (ru) 1983-03-15
FR2451375A1 (fr) 1980-10-10
HU181678B (en) 1983-11-28
DE2964803D1 (en) 1983-03-24
JPS55124782A (en) 1980-09-26
LU81437A1 (fr) 1979-09-12
ES8202341A1 (es) 1980-08-01
DD144671A5 (de) 1980-10-29
JPS6228794B2 (es) 1987-06-23
PT69832A (en) 1979-07-01
AU4841379A (en) 1980-09-18
PL128622B1 (en) 1984-02-29
DK268379A (da) 1980-09-17
PH15302A (en) 1982-11-12

Similar Documents

Publication Publication Date Title
AR228575A1 (es) Procedimiento para obtener derivados de 7-hidroximetil o 7-carboxicamptotecina y sus sales
AR240807A1 (es) Procedimiento para obtener derivados de benzazepin-2-ona y sus sales
AR228444A1 (es) Procedimiento para preparar derivados de 5-bencil-tiazolidin-2,4-diona y sus sales
ES487464A0 (es) Procedimiento de preparacion de nuevos derivados aldehidos peptidil-argininos y de sus sales
AR220686A1 (es) Procedimiento para obtener derivados de 2 amino-2-desoxi-3-o-(propilcarbamoilmetil)-carbamoilmetil-glucopiranosa y sus sales
AR226847A1 (es) Procedimiento para preparar derivados de 1-benzimidazol
ES494668A0 (es) Procedimiento para la preparacion de sales de la (+)-cate- quina
AR227556A1 (es) Procedimiento para preparar derivados de 2-fenil-amino-2-imidazolina y sus sales
AR230280A1 (es) Procedimiento para obtener derivados de carboestirilo y sus sales
ES487584A0 (es) Procedimiento para preparar nuevos derivados de pleuromuti- lin
ES502643A0 (es) Procedimiento para la preparacion de compuestos de aril-fe- nil-acetileno y sus sales amonicas
AR227272A1 (es) Procedimiento para la obtencion de compuestos de n-oxaciclil-alquil-piperidil-diaza y sus sales
AR228144A1 (es) Procedimiento para obtener derivados de 5-fenil-triazolidina-2,4-diona y sus sales
AR218454A1 (es) Procedimiento para preparar derivados de 7-beta-amino o 7-beta-(2-oximino-2-furil o 2-fenilacetamido)-3-(sulfoalquil o 3-sulfoaminalquilo o 3-sulfamilalquil-tetrazol-5-il)tiometil 3-cefem-4-carboxilicos y sus sales
AR228851A1 (es) Procedimiento para preparar 9-hidroxi-9-aminoalquilflourenos y sus sales
AR230046A1 (es) Procedimiento para preparar tetrapeptidos de tyr-d-ala-gly-alquil(c1-c3)o ciclopropilmetil-pheamida y sus sales
AR226578A1 (es) Procedimiento para preparar tetrapeptidos de try-d-ala-gly-l-(n alfa-substituido)-phe-amida y sus sales
AR228036A1 (es) Procedimiento para obtener derivados de 1-tio-alcanoilprolina y sus sales
AR228437A1 (es) Procedimiento para preparar compuestos de 6-fenil-2-oxo-nicotinoilamoxicilina y sus sales
AR223160A1 (es) Procedimiento para preparar derivados de 3-aminoalquiltiazolidindiona(2,4)y sus sales
ES491253A0 (es) Procedimiento para la preparacion de sales de los tiazolili-denoxo-propionitrilos
AR222178A1 (es) Procedimiento para preparar compuestos de 2-aza-6-alquil(c1-c3)-8-o 9-ergoleno y sus sales
AR221352A1 (es) Un procedimiento para preparar derivados de trans-4a-fenil-octahidro-1h2-pirindinas y sus sales
AR226119A1 (es) Procedimiento para preparar derivados de 4-sulfamoilfenil-3-sustituido-2-fenil-imino-4-tiazolina
AR226288A1 (es) Procedimiento para la produccion de nuevas 4-alquiltiofenoxi alquilaminas y sus sales